Cargando…
The Saudi Abnormal Glucose Metabolism and Diabetes Impact Study (SAUDI-DM)
BACKGROUND AND OBJECTIVES: Saudi Arabia underwent opulence-driven socio-cultural and lifestyle changes leading to soaring rates of diabetes mellitus. This study exposes the epidemiology of abnormal glucose metabolism namely: diabetes and impaired fasting glucose (IFG) in 13 administrative regions of...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
King Faisal Specialist Hospital and Research Centre
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074580/ https://www.ncbi.nlm.nih.gov/pubmed/25971818 http://dx.doi.org/10.5144/0256-4947.2014.465 |
_version_ | 1783344443169964032 |
---|---|
author | Al-Rubeaan, Khalid Al-Manaa, Hamad Khoja, Tawfik Ahmad, Najlaa Al-Sharqawi, Ahmad Siddiqui, Khalid AlNaqeb, Dehkra Aburisheh, Khaled Youssef, Amira Al-Batil, Abdullah Al-Otaibi, Metib Al Ghamdi, Ali |
author_facet | Al-Rubeaan, Khalid Al-Manaa, Hamad Khoja, Tawfik Ahmad, Najlaa Al-Sharqawi, Ahmad Siddiqui, Khalid AlNaqeb, Dehkra Aburisheh, Khaled Youssef, Amira Al-Batil, Abdullah Al-Otaibi, Metib Al Ghamdi, Ali |
author_sort | Al-Rubeaan, Khalid |
collection | PubMed |
description | BACKGROUND AND OBJECTIVES: Saudi Arabia underwent opulence-driven socio-cultural and lifestyle changes leading to soaring rates of diabetes mellitus. This study exposes the epidemiology of abnormal glucose metabolism namely: diabetes and impaired fasting glucose (IFG) in 13 administrative regions of Saudi Arabia. DESIGN AND SETTINGS: This is a nationwide, household, population-based cross-sectional study that was conducted through primary health care centers during the period 2007–2009. PATIENTS AND METHODS: A nationwide, household, population-based cohort of 53 370 participants aged 0–100 years adjusted to be compatible with population census was interviewed and anthropometric measures were collected. Fasting blood sample was used to screen for IFG and diabetes. RESULTS: The overall prevalence of abnormal glucose metabolism was 34.5%, which included 22.6% patients with IFG, 11.9% patients with diabetes, and 6.2% patients who unaware of their disease. Diabetes prevalence was 40.2% for subjects aged ≥45 years and 25.4% for those aged ≥30 years that decreased to 11.9% when the full age spectrum was considered. Type 1 diabetes prevalence was 0. 8%, contributing only to 6.6% of the total population of patients with diabetes. The top 5 regions with the highest abnormal glucose metabolism prevalence were Makkah (43.4%), Aljouf (41.7%), Eastern region (37.16%), Madinah (35.4%), and Qassim (33.7%). Urbanization, age, and obesity were behind the wide variations in diabetes and IFG prevalence in the 13 regions. CONCLUSION: Abnormal glucose metabolism has reached an epidemic state in Saudi Arabia, where one-third of the population is affected and half of diabetic cases were unaware of their disease. This observation warrants an urgent strategy for launching diabetes primary prevention and screening programs. |
format | Online Article Text |
id | pubmed-6074580 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | King Faisal Specialist Hospital and Research Centre |
record_format | MEDLINE/PubMed |
spelling | pubmed-60745802018-09-21 The Saudi Abnormal Glucose Metabolism and Diabetes Impact Study (SAUDI-DM) Al-Rubeaan, Khalid Al-Manaa, Hamad Khoja, Tawfik Ahmad, Najlaa Al-Sharqawi, Ahmad Siddiqui, Khalid AlNaqeb, Dehkra Aburisheh, Khaled Youssef, Amira Al-Batil, Abdullah Al-Otaibi, Metib Al Ghamdi, Ali Ann Saudi Med Original Article BACKGROUND AND OBJECTIVES: Saudi Arabia underwent opulence-driven socio-cultural and lifestyle changes leading to soaring rates of diabetes mellitus. This study exposes the epidemiology of abnormal glucose metabolism namely: diabetes and impaired fasting glucose (IFG) in 13 administrative regions of Saudi Arabia. DESIGN AND SETTINGS: This is a nationwide, household, population-based cross-sectional study that was conducted through primary health care centers during the period 2007–2009. PATIENTS AND METHODS: A nationwide, household, population-based cohort of 53 370 participants aged 0–100 years adjusted to be compatible with population census was interviewed and anthropometric measures were collected. Fasting blood sample was used to screen for IFG and diabetes. RESULTS: The overall prevalence of abnormal glucose metabolism was 34.5%, which included 22.6% patients with IFG, 11.9% patients with diabetes, and 6.2% patients who unaware of their disease. Diabetes prevalence was 40.2% for subjects aged ≥45 years and 25.4% for those aged ≥30 years that decreased to 11.9% when the full age spectrum was considered. Type 1 diabetes prevalence was 0. 8%, contributing only to 6.6% of the total population of patients with diabetes. The top 5 regions with the highest abnormal glucose metabolism prevalence were Makkah (43.4%), Aljouf (41.7%), Eastern region (37.16%), Madinah (35.4%), and Qassim (33.7%). Urbanization, age, and obesity were behind the wide variations in diabetes and IFG prevalence in the 13 regions. CONCLUSION: Abnormal glucose metabolism has reached an epidemic state in Saudi Arabia, where one-third of the population is affected and half of diabetic cases were unaware of their disease. This observation warrants an urgent strategy for launching diabetes primary prevention and screening programs. King Faisal Specialist Hospital and Research Centre 2014 /pmc/articles/PMC6074580/ /pubmed/25971818 http://dx.doi.org/10.5144/0256-4947.2014.465 Text en Copyright © 2014, Annals of Saudi Medicine This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Al-Rubeaan, Khalid Al-Manaa, Hamad Khoja, Tawfik Ahmad, Najlaa Al-Sharqawi, Ahmad Siddiqui, Khalid AlNaqeb, Dehkra Aburisheh, Khaled Youssef, Amira Al-Batil, Abdullah Al-Otaibi, Metib Al Ghamdi, Ali The Saudi Abnormal Glucose Metabolism and Diabetes Impact Study (SAUDI-DM) |
title | The Saudi Abnormal Glucose Metabolism and Diabetes Impact Study (SAUDI-DM) |
title_full | The Saudi Abnormal Glucose Metabolism and Diabetes Impact Study (SAUDI-DM) |
title_fullStr | The Saudi Abnormal Glucose Metabolism and Diabetes Impact Study (SAUDI-DM) |
title_full_unstemmed | The Saudi Abnormal Glucose Metabolism and Diabetes Impact Study (SAUDI-DM) |
title_short | The Saudi Abnormal Glucose Metabolism and Diabetes Impact Study (SAUDI-DM) |
title_sort | saudi abnormal glucose metabolism and diabetes impact study (saudi-dm) |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074580/ https://www.ncbi.nlm.nih.gov/pubmed/25971818 http://dx.doi.org/10.5144/0256-4947.2014.465 |
work_keys_str_mv | AT alrubeaankhalid thesaudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT almanaahamad thesaudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT khojatawfik thesaudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT ahmadnajlaa thesaudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT alsharqawiahmad thesaudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT siddiquikhalid thesaudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT alnaqebdehkra thesaudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT aburishehkhaled thesaudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT youssefamira thesaudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT albatilabdullah thesaudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT alotaibimetib thesaudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT alghamdiali thesaudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT alrubeaankhalid saudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT almanaahamad saudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT khojatawfik saudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT ahmadnajlaa saudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT alsharqawiahmad saudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT siddiquikhalid saudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT alnaqebdehkra saudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT aburishehkhaled saudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT youssefamira saudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT albatilabdullah saudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT alotaibimetib saudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm AT alghamdiali saudiabnormalglucosemetabolismanddiabetesimpactstudysaudidm |